Search
for
Sort by
Research 721–750 of 1000+
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Clinical and anamnestic features of alopecia areata in ukrainian men
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- Psychological burden of alopecia areata in patients with cancer: A narrative review
- Global, Regional, and National Burden of Alopecia Areata in Children and Adolescents Aged 0-19 years from 1990 to 2021 and Projection to 2040
- A Comparative Study to Evaluate Efficacy of Prachanna Karma Followed by Chirabilva Lepa and Gunja Lepa in the Management of Indralupta w.s.r to Alopecia Areata
- Risk Factors for Pediatric Alopecia Areata: Clinical and Biochemical Findings from a Case – Control Study
- Epidemiology and burden of alopecia areata in Taiwan: a systematic review
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Life Events Preceding Alopecia Areata Onset—a Descriptive Retrospective Cohort Study Focusing on Strain
- PERSONAL EXPERIENCE OF MONOCHROMATIC EXCIMER PHOTOTHERAPY OF ALOPECIA AREATA
- CD27 and IL-35 as diagnostic biomarkers in alopecia areata: First evidence of association with pathogenic scalp bacterial infections
- Association of Serum IL-17A and IL-23 Levels With Alopecia Areata: A Cross-Sectional Comparative Study
- Merciful Malady: Renbök Phenomenon Between Alopecia Areata and Psoriasis Vulgaris
- Features of skinfold thickness in Ukrainian men with alopecia areata
- Comparative Efficacy Evaluation of Alopecia Areata Management with Janus Kinase Inhibitors in Children: Retrospective Cohort Study
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Effectiveness of Baricitinib for Nasal, Genital, and Beard Hair Regrowth in Patients with Severe Alopecia Areata: 12-Month Outcomes from a Prospective Observational Study
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- Clinical Evaluation of Prachchhana Karma and Supportive Ayurvedic Medication in the Management of Indralupta (Alopecia Areata): a Case Study
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Characterization of thyroid disorders in alopecia areata patients: A cross-sectional evaluation
- Meta-Analysis of Gene Expression Reveals the Core Transcriptomic Profile of Lesional Scalp in Alopecia Areata
- Alopecia Areata Associated with Dupilumab: A Case Report and Literature Review
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- COMPARATIVE EFFICACY OF TOPICAL CLOBETASOL PROPIONATE 0.05% OINTMENT AND TOPICAL TACROLIMUS 0.1% OINTMENT IN THE TREATMENT OF ALOPECIA AREATA
- Consider Cultural Practices and Barriers to Care When Treating Alopecia Areata
- Discriminative models of the possibility of occurrence and features of the course of alopecia areata in Ukrainian men depending on the features of body structure and size indicators